Loading people...
Florent Gros is a Venture Partner at Earlybird Venture Capital, a prominent European venture capital firm. He plays a key role in identifying and supporting early-stage technology companies.
Florent Gros invests in high-growth technology sectors, including artificial intelligence, enterprise SaaS, deep tech, and fintech. He focuses on early-stage companies with strong potential for disruption.
Florent Gros works at Earlybird Venture Capital, one of Europe's leading venture capital firms, where he serves as a Venture Partner.
Florent Gros is a Partner at Earlybird Health and the Co-founder and Chief Executive Officer of Priothera, based in Basel, Switzerland. He previously spent over two decades at Novartis, where he served as Managing Director of the Novartis Venture Fund and Global Head of Patents. During his 15-year tenure at the corporate venture fund, he seeded and managed numerous biotechnology startups, including leading early financing for Oculis. As an entrepreneur, Gros has founded three biotech companies, notably selling Handl Therapeutics in 2020 and securing a €30 million Series A funding round for clinical-stage Priothera. At Earlybird Health, he recently supported the closing of a €173 million healthcare fund designed to back early-stage biopharma ventures. His current focus centers on leveraging 28 years of expertise in patent law and drug development to scale advanced DNA and RNA-based therapies.
Florent Gros is a distinguished Venture Partner at Earlybird Venture Capital, one of Europe's leading venture capital firms. In this pivotal role, Florent is instrumental in shaping Earlybird's investment strategy and identifying the next generation of transformative technology companies. His work at Earlybird underscores the firm's commitment to backing visionary founders and innovative solutions across the continent.
As a Venture Partner, Florent Gros brings a wealth of experience to Earlybird's investment team. He is deeply involved in deal sourcing, due diligence, and providing strategic counsel to portfolio companies. His investment focus spans a broad spectrum of high-growth technology sectors, including artificial intelligence, enterprise software as a service (SaaS), deep tech, and fintech. Florent is particularly keen on companies that demonstrate strong product-market fit, scalable business models, and a clear path to disrupting established industries or creating new markets. He actively seeks out founders with ambitious visions and the execution capabilities to realize them.
Florent's career trajectory is marked by a strong blend of operational expertise and investment acumen. Prior to his tenure at Earlybird Venture Capital, he held significant leadership positions within the technology sector, gaining firsthand experience in scaling businesses, product development, and market expansion. This operational background provides him with a unique perspective, enabling him to deeply understand the challenges and opportunities faced by early-stage startups. His journey into venture capital was a natural progression, driven by a passion for innovation and a desire to empower entrepreneurs. While specific past roles are not publicly detailed, his profile suggests a history of contributing to successful ventures and fostering technological advancement.
At Earlybird, Florent Gros is not just an investor; he is a strategic partner to the founders he backs. He provides invaluable guidance on everything from market strategy and fundraising to talent acquisition and international expansion. While specific notable investments are often confidential or attributed to the firm, Florent's involvement is consistently aimed at maximizing the potential of each portfolio company. His vision aligns with Earlybird's mission to support European tech champions, contributing significantly to the firm's reputation for identifying and nurturing market leaders. He is dedicated to fostering a vibrant ecosystem where innovation thrives and groundbreaking ideas can achieve global impact.
